메뉴 건너뛰기




Volumn 15, Issue 5, 2009, Pages 596-598

Intravenous and oral sulodexide versus coagulation activation markers in humans

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DALTEPARIN; HEPARIN; PROTHROMBIN; SULODEXIDE; THROMBIN ANTITHROMBIN COMPLEX;

EID: 70449658196     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609333674     Document Type: Letter
Times cited : (10)

References (16)
  • 1
    • 0031974383 scopus 로고    scopus 로고
    • Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide
    • Harenberg J. Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med Res Rev. 1998 ; 18: 1-20.
    • (1998) Med Res Rev , vol.18 , pp. 1-20
    • Harenberg, J.1
  • 2
    • 0031938089 scopus 로고    scopus 로고
    • Pharmacological actions of sulodexide
    • Ofosu FA Pharmacological actions of sulodexide. Semin Thromb Hemost. 1998 ; 24: 127-138.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 127-138
    • Ofosu, F.A.1
  • 3
    • 33746691250 scopus 로고    scopus 로고
    • The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy
    • Abaterusso C., Gambaro G. The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. Treat Endocrinol. 2006 ; 5: 211-222.
    • (2006) Treat Endocrinol , vol.5 , pp. 211-222
    • Abaterusso, C.1    Gambaro, G.2
  • 4
    • 33847767217 scopus 로고    scopus 로고
    • Sulodexide: A renewed interest in this glycosaminoglycan
    • Lauver DA, Lucchesi BR Sulodexide: a renewed interest in this glycosaminoglycan. Cardiovasc Drug Rev. 2006 ; 24: 214-226.
    • (2006) Cardiovasc Drug Rev , vol.24 , pp. 214-226
    • Lauver, D.A.1    Lucchesi, B.R.2
  • 5
    • 33847302393 scopus 로고    scopus 로고
    • Sulodexide induces hepatocyte growth factor release in humans
    • Borawski J., Dubowski M., Pawlak K., Mysliwiec M. Sulodexide induces hepatocyte growth factor release in humans. Eur J Pharmacol. 2007 ; 558: 167-171.
    • (2007) Eur J Pharmacol , vol.558 , pp. 167-171
    • Borawski, J.1    Dubowski, M.2    Pawlak, K.3    Mysliwiec, M.4
  • 6
    • 58449135502 scopus 로고    scopus 로고
    • Pleiotropic effects of heparin and heparinoids in peritoneal dialysis
    • 2009
    • Gozdzikiewicz J., Borawski J., Mysliwiec M. Pleiotropic effects of heparin and heparinoids in peritoneal dialysis. Clin Appl Thromb Hemost. 2009. doi:10.1177/ 1076029607304722. Already published 2009 ; 15: 92-97.
    • (2009) Clin Appl Thromb Hemost , vol.15 , pp. 92-97
    • Gozdzikiewicz, J.1    Borawski, J.2    Mysliwiec, M.3
  • 7
    • 76049101885 scopus 로고    scopus 로고
    • Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers
    • Borawski J., Dubowski M., Pawlak K., Mysliwiec M. Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers. Clin Appl Thromb Hemost. 2008 doi:10.1177/1076029608326170.
    • (2008) Clin Appl Thromb Hemost
    • Borawski, J.1    Dubowski, M.2    Pawlak, K.3    Mysliwiec, M.4
  • 8
    • 0028641215 scopus 로고
    • Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo
    • Eichinger S., Wolz M., Nieszpaur-Los M., et al. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo. Thromb Haemost. 1994 ; 72: 831-835.
    • (1994) Thromb Haemost , vol.72 , pp. 831-835
    • Eichinger, S.1    Wolz, M.2    Nieszpaur-Los, M.3
  • 9
    • 0026643206 scopus 로고
    • Influence of heparin treatment on biochemical markers of an activation of the coagulation system
    • Amelsberg A., Zurborn KH, Gartner U., Kiehne KH, Preusse AK, Bruhn HD Influence of heparin treatment on biochemical markers of an activation of the coagulation system. Thromb Res. 1992 ; 66: 121-131.
    • (1992) Thromb Res , vol.66 , pp. 121-131
    • Amelsberg, A.1    Zurborn, K.H.2    Gartner, U.3    Kiehne, K.H.4    Preusse, A.K.5    Bruhn, H.D.6
  • 10
    • 43249130447 scopus 로고    scopus 로고
    • Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II
    • He L., Giri TK, Vicente CP, Tollefsen DM Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood. 2008 ; 111: 4118-4125.
    • (2008) Blood , vol.111 , pp. 4118-4125
    • He, L.1    Giri, T.K.2    Vicente, C.P.3    Tollefsen, D.M.4
  • 11
    • 0035805579 scopus 로고    scopus 로고
    • Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin
    • Chuang YJ, Swanson R., Raja SM, Olson ST Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J Biol Chem. 2001 ; 276: 14961-14967.
    • (2001) J Biol Chem , vol.276 , pp. 14961-14967
    • Chuang, Y.J.1    Swanson, R.2    Raja, S.M.3    Olson, S.T.4
  • 12
    • 33746704346 scopus 로고    scopus 로고
    • Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndrome
    • van der Putten RFM, Glatz JFC, Hermens WT Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndrome. Clin Chim Acta. 2006 ; 371: 37-54.
    • (2006) Clin Chim Acta , vol.371 , pp. 37-54
    • Van Der Putten, R.F.M.1    Glatz, J.F.C.2    Hermens, W.T.3
  • 13
    • 0027414751 scopus 로고
    • Prothrombin fragment F1+2 concentrations for monitoring anticoagulation therapy with heparin
    • Brack MJ, More RS, Hubner PJ, Gershlick AH Prothrombin fragment F1+2 concentrations for monitoring anticoagulation therapy with heparin. Int J Cardiol. 1993 ; 38: 57.
    • (1993) Int J Cardiol , vol.38 , pp. 57
    • Brack, M.J.1    More, R.S.2    Hubner, P.J.3    Gershlick, A.H.4
  • 14
    • 0030995765 scopus 로고    scopus 로고
    • Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators
    • Feinberg WM, Cornell ES, Nightingale SD, et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke. 1997 ; 28: 1101-1106.
    • (1997) Stroke , vol.28 , pp. 1101-1106
    • Feinberg, W.M.1    Cornell, E.S.2    Nightingale, S.D.3
  • 15
    • 0025834924 scopus 로고
    • Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities
    • Linhardt RJ, al- Hakim A., Liu JA, et al. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochem Pharmacol. 1991 ; 42: 1609-1619.
    • (1991) Biochem Pharmacol , vol.42 , pp. 1609-1619
    • Linhardt, R.J.1    Hakim, A.2    Liu, J.A.3
  • 16
    • 0035877794 scopus 로고    scopus 로고
    • Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin
    • Liaw PC, Becker DL, Stafford AR, Fredenburgh JC, Weitz JI Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin. J Biol Chem. 2001 ; 276: 20959-20965.
    • (2001) J Biol Chem , vol.276 , pp. 20959-20965
    • Liaw, P.C.1    Becker, D.L.2    Stafford, A.R.3    Fredenburgh, J.C.4    Weitz, J.I.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.